Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $1.78 Million - $2.14 Million
12,900 Added 34.86%
49,900 $8.06 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $13,421 - $15,393
-100 Reduced 0.27%
37,000 $4.97 Million
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $2.35 Million - $2.99 Million
17,100 Added 85.5%
37,100 $5.68 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $1.16 Million - $1.44 Million
-8,800 Reduced 30.56%
20,000 $3.24 Million
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $1.1 Million - $1.39 Million
10,200 Added 54.84%
28,800 $3.9 Million
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $266,000 - $301,950
2,500 Added 15.53%
18,600 $2.01 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $1.75 Million - $1.95 Million
-16,600 Reduced 50.76%
16,100 $1.81 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $2.12 Million - $2.33 Million
20,700 Added 172.5%
32,700 $3.5 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $965,879 - $1.3 Million
12,000 New
12,000 $1.27 Million
Q2 2020

Aug 06, 2020

SELL
$73.37 - $98.18 $2.86 Million - $3.83 Million
-39,000 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $928,800 - $1.41 Million
-14,400 Reduced 26.97%
39,000 $2.93 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $115,408 - $144,400
-1,600 Reduced 2.91%
53,400 $4.73 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $3.46 Million - $4.16 Million
55,000 New
55,000 $4.17 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mint Tower Capital Management B.V. Portfolio

Follow Mint Tower Capital Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.